Search research articles
Contact Us
Filters
Showing results (961-970 of 973) with videos related to
Page
of 98
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2026
Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program
Elyse R Park, JoRean D Sicks, Brett M Goshe, et al.
Cell Metabolism
|
January 8, 2008
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
Carol Addy, Hamish Wright, Koen Van Laere, et al.
The Lancet. Infectious Diseases
|
September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Science Translational Medicine
|
November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
Christopher D Petro, Andrea T Hooper, Avery Peace, et al.
Cell
|
June 23, 2021
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin, Alina Baum, Elzbieta Wloga, et al.
Science Translational Medicine
|
November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
Judith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
The New England Journal of Medicine
|
October 14, 2025
DB-OTO Gene Therapy for Inherited Deafness
Vassili Valayannopoulos, Manohar Bance, Daniela S Carvalho, et al.
Nature Medicine
|
September 28, 2023
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers
D Bennett, M Wierdl, S Chakraborty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial
Sumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Page
of 98
Search research articles
Search
Showing results (961-970 of 973) with videos related to
Sort By:
Page
of 98
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2026
Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program
Elyse R Park, JoRean D Sicks, Brett M Goshe, et al.
Cell Metabolism
|
January 8, 2008
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
Carol Addy, Hamish Wright, Koen Van Laere, et al.
The Lancet. Infectious Diseases
|
September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Science Translational Medicine
|
November 6, 2024
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
Christopher D Petro, Andrea T Hooper, Avery Peace, et al.
Cell
|
June 23, 2021
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
Richard Copin, Alina Baum, Elzbieta Wloga, et al.
Science Translational Medicine
|
November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
Judith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
The New England Journal of Medicine
|
October 14, 2025
DB-OTO Gene Therapy for Inherited Deafness
Vassili Valayannopoulos, Manohar Bance, Daniela S Carvalho, et al.
Nature Medicine
|
September 28, 2023
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers
D Bennett, M Wierdl, S Chakraborty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial
Sumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Page
of 98